TD Cowen Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $22.00

Acadia Healthcare (NASDAQ:ACHC) had its price target decreased by TD Cowen from $25.00 to $22.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. TD Cowen’s price target points to a potential upside of 88.36% from the stock’s current price.

Other equities analysts have also recently issued reports about the stock. KeyCorp lowered their price target on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 3rd. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating for the company in a report on Wednesday. Leerink Partners reissued a “market perform” rating and set a $14.00 price target (down previously from $25.00) on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Guggenheim dropped their price objective on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Monday, November 10th. Finally, UBS Group decreased their target price on Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $18.92.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $11.68 on Friday. The stock has a market capitalization of $1.08 billion, a price-to-earnings ratio of 9.98, a PEG ratio of 3.06 and a beta of 0.88. The business’s 50 day moving average is $14.77 and its two-hundred day moving average is $19.95. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $45.61. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. The business had revenue of $851.57 million during the quarter, compared to analysts’ expectations of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the firm earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Research analysts expect that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth about $1,600,000. Goldman Sachs Group Inc. lifted its stake in shares of Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after buying an additional 121,444 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Acadia Healthcare by 8.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after acquiring an additional 27,207 shares during the last quarter. Parallel Advisors LLC grew its stake in Acadia Healthcare by 1,120.3% in the 2nd quarter. Parallel Advisors LLC now owns 5,174 shares of the company’s stock worth $117,000 after acquiring an additional 4,750 shares during the period. Finally, Counterpoint Mutual Funds LLC acquired a new position in Acadia Healthcare in the 2nd quarter valued at $736,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.